CSIRO and 360BioLabs who have been successful in securing a CRC-P grant to develop an antibody based in vitro diagnostic for metastatic cancer
Congratulations to to BioMelbourne Network members – CSIRO and 360BioLabs – who have been successful in securing a CRC-P grant to develop an antibody based in vitro diagnostic for metastatic cancer. This is the first round of the…
‘Holy grail’ of breast cancer prevention in high-risk women may be in sight
June 21st, 2016 Walter and Eliza Hall Institute researchers have discovered that an existing medication could have promise in preventing breast cancer in women carrying a faulty BRCA1 gene. This could mean that women with high genetic risk…
Retiring LBT Innovations CEO Lusia Guthrie Appointed Chair of Clever Culture Systems AG
Adelaide, Australia, 10 June 2016: The co-founder and Chief Executive of Australian laboratory automation company LBT Innovations Limited (LBT), Mrs Lusia Guthrie, has been appointed Chair of Clever Culture Systems AG (CCS) for a 2-year period from June…
